Palvella Therapeutics (PVLA) EPS (Basic) (2013 - 2026)
Palvella Therapeutics (PVLA) reported EPS (Basic) of -$1.2 for Q1 2026, down 62.16% year-over-year from -$3.17 in Q1 2025, and down 11.11% on a QoQ basis from -$1.08 in Q4 2025.
Palvella Therapeutics (PVLA) has 14 years of EPS (Basic) data on file, last reported at -$1.2 in Q1 2026.
- Quarterly EPS (Basic) fell 62.16% year-over-year to -$1.2 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$4.17 (up 40.68% YoY) and the FY2025 annual result came in at -$3.71, up 52.62% from the prior year.
- EPS (Basic) retreated to -$1.2 in Q1 2026 per PVLA's latest filing, from -$1.08 in the prior quarter.
- Across five years, EPS (Basic) topped out at $20.52 in Q4 2023 and bottomed at -$14.15 in Q1 2023.
- The 5-year median for EPS (Basic) is -$0.94 (2025), against an average of -$0.74.
- Peak annual rise in EPS (Basic) reached 2692.86% in 2023, while the deepest fall reached 20114.29% in 2023.
- Tracing PVLA's EPS (Basic) over 5 years: stood at -$0.13 in 2022, then soared by 15884.62% to $20.52 in 2023, then tumbled by 99.42% to $0.12 in 2024, then plunged by 1000.0% to -$1.08 in 2025, then dropped by 11.11% to -$1.2 in 2026.
- Per Business Quant, the three latest PVLA EPS (Basic) figures stand at -$1.2 (Q1 2026), -$1.08 (Q4 2025), and -$1.03 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 3.06 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 0.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 0.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 4.06 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 0.00 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 6.99 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1.55 |
| 10 | Palvella Therapeutics | 1.47 Bn | 1.21 Bn | - | -1.20 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.20 |
| Dec 31, 2025 | -1.08 |
| Sep 30, 2025 | -1.03 |
| Jun 30, 2025 | -0.86 |
| Mar 31, 2025 | -0.74 |
| Dec 31, 2024 | 0.12 |
| Sep 30, 2024 | -3.94 |
| Jun 30, 2024 | -2.47 |
| Mar 31, 2024 | -1.54 |
| Dec 31, 2023 | 20.52 |
| Sep 30, 2023 | -8.70 |
| Jun 30, 2023 | 3.63 |
| Mar 31, 2023 | -14.15 |
| Sep 30, 2022 | -0.13 |
| Jun 30, 2022 | -0.14 |
| Mar 31, 2022 | -0.07 |
| Dec 31, 2021 | -0.13 |
| Sep 30, 2021 | -0.24 |
| Jun 30, 2021 | -0.25 |
| Mar 31, 2021 | -0.07 |
| Dec 31, 2020 | -0.26 |
| Sep 30, 2020 | -0.26 |
| Jun 30, 2020 | -0.09 |
| Mar 31, 2020 | -0.07 |
| Dec 31, 2019 | -0.06 |
| Sep 30, 2019 | -0.05 |
| Jun 30, 2019 | -0.24 |
| Mar 31, 2019 | -0.20 |
| Dec 31, 2018 | -0.21 |
| Sep 30, 2018 | -0.11 |
| Jun 30, 2018 | 0.00 |
| Mar 31, 2018 | -0.17 |
| Dec 31, 2017 | 0.18 |
| Sep 30, 2017 | -0.16 |
| Jun 30, 2017 | -0.23 |
| Mar 31, 2017 | -0.19 |
| Dec 31, 2016 | -0.16 |
| Sep 30, 2016 | -0.14 |
| Jun 30, 2016 | -0.14 |
| Mar 31, 2016 | -0.10 |
| Dec 31, 2015 | -0.07 |
| Sep 30, 2015 | -0.10 |
| Jun 30, 2015 | -0.12 |
| Mar 31, 2015 | -0.13 |
| Sep 30, 2014 | -0.17 |
| Jun 30, 2014 | -0.24 |
| Mar 31, 2014 | -0.07 |
| Dec 31, 2013 | 0.00 |
| Sep 30, 2013 | 0.00 |
| Jun 30, 2013 | 0.00 |